Osteoporosis is an underdiagnosed disease. Patients with circumscribed risk factors should not be deprived of a bone density measurement. Although osteoporosis cannot be completely cured, its progression can be delayed with effective treatment. The current guideline defines treatment indication thresholds for the use of specific osteoporosis drugs (antiresorptives, osteoanabolics). In general, treatment should be tailored to the patient’s individual situation.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- From symptom to diagnosis
Pneumology – Covid-19: a review
- Abdominal aortic aneurysms in primary care
Risk-stratified screening and prophylaxis
- Cardiology
Minimally invasive – the quiet triumph of modern heart surgery
- Plastic surgery and reconstructive microsurgery for DFS
Functional limb preservation between infection control, vascular medicine and resurfacing
- Age-related neurocognitive disorders
Neuroprotective effects of Ginkgo biloba extract
How origin and place of residence promote CF-associated diabetes
- Patients with leg swelling
DVT and other common DDs with peripheral edema
- "smarter medicine": Top 5 list for headache treatment